1. European Commission. Community register of veterinary medicinal products, Product information, Annex 1 Summary of product characteristics Bravecto Plus spot-on solution for cats. 2018.
http://ec.europa.eu/health/documents/community-register/2018/20180508140629/anx_140629_en.pdf
. Accessed 25 Jun 2018.
2. European Commission. Community register of veterinary medicinal products, Product information, Annex 1 Summary of product characteristics Bravecto spot-on solution for cats. 2018.
http://ec.europa.eu/health/documents/community-register/2018/20180319140371/anx_140371_en.pdf
. Accessed 22 Aug 2018.
3. Rohdich N, Zschiesche E, Wolf O, Loehlein W, Pobel T, Gil MJ, et al. Field effectiveness and safety of fluralaner plus moxidectin (Bravecto® Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats. Parasit Vectors. 2018 (In Press).
4. Rohdich N, Zschiesche E, Wolf O, Loehlein W, Kirkova Z, Iliev P, et al. A randomized, blinded, controlled, multi-centered field study assessing the treatment of nematode infections in cats with fluralaner plus moxidectin spot-on solution (Bravecto® Plus). Parasit Vectors. 2018 (In Press).
5. Department for Environment Food & Rural Affairs, Veterinary Medicines Directorate. Summary of product characteristics Droncit Spot-on 20 mg Solution. 2017.
http://www.vmd.defra.gov.uk/productinformationdatabase/SPC_Documents/SPC_137995.DOC
. Accessed 25 Jun 2018.